AN AREA of Scotland has been revealed as a world hotspot for Huntington’s disease. New research has revealed the shockingly ...

The US Food and Drug Administration (FDA) has awarded breakthrough therapy designation to uniQure's AMT-130 for treating ...

Northern Scotland has one of the highest rates of Huntington’s disease in the world, a study has found. The number of people ...

Steminent Biotherapeutics specializes in developing innovative stem cell-based therapeutics that offer new hope for patients ...

AMT-130 is administered through magnetic resonance imaging-guided, convection-enhanced stereotactic neurosurgical delivery into the striatum.

The flight, carrying celebrities like Katy Perry and Gayle King, reached a height of about 60 miles (96.6km) above Earth.

Sandy Patience says he is 'proud to break the mould' and take part in a clinical trial to develop treatments for Huntington's ...

Qure's AMT-130 shows 80% Huntington's Disease progression slowing. Click to read more on QURE's financially strong, advancing ...

"Pridopidine shows long-term sustained efficacy up to 2 years, and there's significant long-term benefit confirmed compared ...

Factors driving the market include rising disease prevalence, innovative therapies, and gene-based treatment breakthroughs. Key players like H Lundbeck and Pfizer are fueling research and development ...

Qure's long-term success hinges on overcoming regulatory and logistical challenges. See why I rate QURE stock a hold.